01 — At a Glance
From Telecom Ghost to Defence Avengers
- 52-Week High / Low₹234 / ₹49.1
- Q3 FY26 Revenue₹145.7 Cr
- Q3 FY26 PAT-₹1.03 Cr
- Q3 FY26 EPS-₹0.14
- 6-Month Return+10.2%
- Book Value₹38.0
- Price to Book4.55x
- Dividend Yield0.00%
- Debt / Equity0.01x
- 1-Year Return+224%
Full Context: Sigma Advanced Systems (formerly Megasoft Ltd) just completed an amalgamation with Sigma Advanced Systems Private Limited in December 2025. In Q3, revenue exploded 667% YoY to ₹145.7 crore, driven by aerospace & defence orders. But profit is negative. The company just sold 36.52% of Extrovis AG for ₹137.61 crore, raising cash for growth. Stock up 224% in one year. P/E of 21.3x on negative earnings. Auditors call this a “financial engineering exercise.” We call it Thursday.
02 — Introduction
When a Telecom Company Becomes a Defence Contractor (Without Telling Anyone)
Imagine your uncle ran a struggling telecom business for 20 years, lost money regularly, and spent weekends betting on everything from IT to pharmaceuticals like a mutual fund manager with no due diligence. Then one day he says, “Enough. I’m pivoting to defence.” No consultant. No board meeting. Just — “We’re buying aerospace companies now.”
Welcome to the origin story of Sigma Advanced Systems Limited. Formerly Megasoft Ltd, a company so diverse in its failures that it made conglomerates look like focus funds. Telecom that didn’t work. Pharma investments in Switzerland that eventually got divested for USD 15 million. Real estate deals that went nowhere. GST disputes involving ₹28 crores.
Then, in a masterstroke of “last-chance desperation meets sudden clarity,” the company acquired Sigma Advanced Systems Private Limited — a 27-year-old aerospace & defence electronics player — merged them via NCLT (National Company Law Tribunal), renamed itself, and suddenly started talking like a defence contractor. Effective December 31, 2025, Megasoft died. Sigma Advanced Systems was born. And within months, they announced ₹100 crore in Ministry of Defence orders.
The stock price, naturally, responded like a teenager finding out free PUBG was available. Up 224% in one year. Q3 revenue spiked 667% YoY. But earnings are negative, the company is heavily working-capital dependent, and the entire growth narrative rests on successfully executing defence contracts — the kind of orders that take 2–3 years to deliver and come with penalty clauses that would make loan sharks weep.
The Plot Twist Nobody Expected: Megasoft sold off 36.52% of its Extrovis pharmaceutical stake in March 2026 for ₹137.61 crore. That’s the company’s “plan B” if defence orders don’t materialise. Classic.
03 — Business Model: WTF Actually Happened Here?
Aerospace, Defence, and The Audacity of a Complete Rebrand
Members get full access to every article.
